Steve La Neve serves as Chief Executive Officer of Accuray, bringing over 40 years of global experience in medical technology and biotechnology, spanning capital equipment and implantable devices. He is recognized for driving operational excellence and delivering sustained value creation.

Prior to Accuray, Steve held several senior executive roles, including President of Globus Medical Japan K.K. and President of Globus Medical Trauma and Joint Reconstruction, a leading musculoskeletal technology company. He also served as Global Sector President for Medtronic’s Spine and Biologics Division. Across these roles, Steve consistently optimized operations, managed costs, achieved financial targets, and expanded revenue streams through innovative technology platforms.

Steve also served as CEO and Board Director of Bone Biologics Corporation, and as President & CEO of ETEX Corporation, where he led the successful sale of the business to a global leader in joint reconstruction. As Global President of Pre-Analytical Systems at Becton Dickinson, he drove revenue and profit growth that outpaced market performance.

Steve holds an MBA from West Chester University and a Bachelor of Science in Health Planning and Administration from Pennsylvania State University. He is a member of Omicron Delta Epsilon, an international honor society recognizing academic excellence and achievements in economics.

Class III Director, Term Expires 2027